跳到正文
cccskills
免费在 GitHub 公开

esa-pa-pediatric-bp-target

Establishes age- and gender-specific blood pressure goals for pediatric patients with primary aldosteronism (PA) using published normative data to assess treatment adequacy and avoid over-treatment. Use when managing hypertension in children with PA to evaluate if BP is adequately controlled; triggers include pediatric PA hypertension, BP not normalized with glucocorticoid therapy, and need for age‑specific BP targets.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL星标 14(GitHub 14 + cccskills 0)

实测评分 未实测

查看安装方法

包含的文件(1)

  • SKILL.md2.5 KB

SKILL.md(原文)

安装前可以查看交给 AI 代理的指令内容。

Determine Blood Pressure Targets for Children with PA

STEP 1 — Gather Information

Collect patient age (years), sex, height (or BMI), weight, current systolic/diastolic BP, glucocorticoid type and dose, confirmation of PA (e.g., GRA genotype or clinical diagnosis), and any comorbidities. → Proceed to STEP 2.

STEP 2 — Rule In / Rule Out

Determine if the patient is a child (<18 years) with confirmed PA requiring glucocorticoid therapy; if not, the skill does not apply (stop). If yes, proceed to STEP 3.

STEP 3 — Classify or Stratify

Using age‑, sex‑, and height‑specific normative BP tables (e.g., NIH childhood BP percentiles), calculate the 90th percentile systolic and diastolic BP as the treatment target; if height unavailable, use age‑sex 90th percentile from population norms. → Proceed to STEP 4.

STEP 4 — Decide

If current BP ≤ target, maintain current glucocorticoid dose; if current BP > target, consider increasing glucocorticoid dose (weight‑adjusted) or adding an MR antagonist, then re‑evaluate BP in 2–4 weeks. → End.

Clinical Guardrails / Mimics / Pitfalls

Avoid excessive glucocorticoid dosing that can cause growth retardation, cushingoid features, or adrenal suppression; do not apply adult BP thresholds (140/90 mmHg) to children; ensure normative data match the child's ethnicity and height; monitor for hypokalemia when adding MR antagonist; do not ignore weight‑based glucocorticoid adjustments.

Concrete Clinical Example

9‑year‑old girl with GRA on prednisone 5 mg daily, BP 128/82 mm Hg, height 130 cm (50th percentile). Age‑sex‑height 90th percentile BP is 115/72 mm Hg; current BP exceeds target, so increase prednisone to 7.5 mg daily and recheck BP in 3 weeks.

Source: The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI:10.1210/jc.2015-4061

TODO: consider adding scripts/calc.py for the esa-pa-pediatric-bp-target calculator

评价

还没有评价。欢迎分享你的使用感受。

评论

无需登录即可发表。欢迎分享使用感受、提问,或说明在哪些环境下无法运行。

还没有评论。来写第一条吧。

提交后会立即公开。请勿填写邮箱、电话等个人信息。URL 最多 2 个。

0 / 1000 字

此表单受 reCAPTCHA 保护,适用 Google 的隐私权政策和服务条款。

同一仓库的技能

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

查看 dromlakhani 的全部技能

报告此技能的问题